Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective

Background Ustekinumab is an interleukin 12/23 inhibitor, approved by the US-FDA for the management of moderate-to-severe plaque psoriasis and psoriatic arthropathy. Purpose This review aims to describe the dermatological implications and applications of ustekinumab. Methodology PubMed and Google Sc...

Full description

Saved in:
Bibliographic Details
Published inJournal of Pharmacology and Pharmacotherapeutics Vol. 15; no. 2; pp. 105 - 121
Main Authors Bubna, Aditya Kumar, Viplav, Vinayak
Format Book Review Journal Article
LanguageEnglish
Published New Delhi, India SAGE Publications 01.06.2024
Sage Publications Ltd
Subjects
Online AccessGet full text

Cover

Loading…